Health8 months ago
New Zealand Welcomes GLP-1 Weight Loss Drugs: Benefits and Risks
The recent approval of GLP-1 receptor agonists, including Wegovy and Saxenda, marks a significant development in New Zealand’s fight against obesity. These drugs are now available...
